P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

• Huilai Zhang,
• Ying Cheng,
• Hai-Yan Yang,
• Liling Zhang,
• Liqun Zou,
• Ye Guo,
• Junning Cao,
• Huiqiang Huang,
• Zhao Wang,
• Sha Huang,
• Zhiyu Liang,
• Jiaoyan Lyu,
• Yiqian Fang,
• Aileen Cohen,
• Keshu Zhou

Affiliations

Huilai Zhang

1 Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Ying Cheng

2 Jilin Cancer Hospital, Changchun, China

Hai-Yan Yang

3 The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China

Liling Zhang

4 Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Liqun Zou

5 West China Hospital, Sichuan University, Chengdu, China

Ye Guo

6 Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China

Junning Cao

7 Fudan University Shanghai Cancer Center, Shanghai, China

Huiqiang Huang

8 Sun Yat-Sen University Cancer Center, Guangzhou, China

Zhao Wang

9 Beijing Friendship Hospital, Capital Medical University, Beijing, China

Sha Huang

10 BeiGene (Shanghai) Co., Ltd. Shanghai, China, BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, United States

Zhiyu Liang

10 BeiGene (Shanghai) Co., Ltd. Shanghai, China, BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, United States

Jiaoyan Lyu

10 BeiGene (Shanghai) Co., Ltd. Shanghai, China, BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, United States

Yiqian Fang

10 BeiGene (Shanghai) Co., Ltd. Shanghai, China, BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, United States

Aileen Cohen

10 BeiGene (Shanghai) Co., Ltd. Shanghai, China, BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, United States

Keshu Zhou

11 Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China